Contribute
España
Italia
대한민국
日本
Français

Benzinga

Research
My Stocks
Tools
Free Benzinga Pro Trial
SPY
765.370.03%
QQQ
709.600.05%
BTC/USD
77581.130.3428%
DIA
530.790.03%
GLD
402.030.19%
TLT
81.95-

bioAffinity Technologies Inc (BIAF) Stock Price, Quote, News & History

BIAFNASDAQ
Trade with Public
Trade with Public
$9.75
3.1647.95%
At close: Sep 2, 5:00 PM EST
$10.00
0.252.56%
After Hours: 7:59 PM EST
PRO
Why Is It Moving?™:bioAffinity Technologies shares are trading higher after the company announ...
OverviewNewsEarnings ForecastPrice TargetsFinancialsSentimentOwnershipCompareStock Report

Key Statistics

Open
$7.61
Close
$9.75
Volume / Avg.
46.05M / 928.40K
Day Range
$7.54 - $11.75
52 Wk Range
4.56 - 202.50
Market Cap
$5.92M
P/E Ratio
-
Dividend Yield
-
Exchange
NASDAQ
RSI
64
Short Interest
33.36%
Days to Cover
1

Recent bioAffinity Technologies Inc News

BioAffinity Technologies Stock Skyrockets Wednesday: What's Happening?

bioAffinity Technologies is surging Wednesday as traders digest recent commercial expansion news alongside tight low-float trading dynamics.
Henry Khederian

Dow Surges Over 200 Points; Ollie's Bargain Outlet Shares Gain After Q2 Earnings

U.S. stocks edged higher, led by the Dow and materials. Ollie’s beat EPS estimates; biotech and AI shares surged, while Tscan plunged 26%.
Avi Kapoor

BioAffinity Advances Noninvasive CyPath Lung Test For Post-Treatment Monitoring

bioAffinity stock trades higher as it advances its CyPath Lung test for post-treatment lung cancer surveillance.
Vandana Singh

Crude Oil Surges 3%; ISM Manufacturing PMI Falls In August

U.S. stocks traded lower midway through trading, with the Nasdaq Composite falling more than 100 points on Tuesday.The Dow traded down 0.40% to 52,971.81 while the NASDAQ dipped 0.52% to 26,232.46. The S&P 500 also
Avi Kapoor

Dow Dips Over 300 Points; Medtronic Shares Gain After Upbeat Q1 Earnings

U.S. stocks traded lower this morning, with the Dow Jones index falling more than 300 points on Tuesday. Following the market opening Tuesday, the Dow traded down 0.58% to 52,876.43 while the NASDAQ dipped 1.40% to
Avi Kapoor

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change

Cash Flows

Operating Cash Flow (TTM)
-11.47M
Investing Cash Flow (TTM)
-91.99K
Financing Cash Flow (TTM)
13.19M
Free Cash Flow (TTM)
-11.56M
Capital Expenditure (TTM)
-91.99K
Net Change in Cash (TTM)
1.63M

Valuation Metrics

Enterprise Value
$2.91M
PE Ratio (TTM)
-
PE Ratio (FWD)
-
PEG Ratio (TTM)
-
PS Ratio (TTM)
0.29
PB Ratio (TTM)
1.04
Earnings Yield % (TTM)
-20.45%
Earnings Yield % (FWD)
-
EV / EBITDA (TTM)
-
Price / EBITDA (TTM)
-
Price / Free Cash Flow (TTM)
-
Book Value / Share
$6.36

Company Debt

Total Debt
$59.03K
LT Debt
$36.47K
LT Debt Issuance (TTM)
-
LT Debt Repayment (TTM)
-$248.17K
Total Cash
$2.43M
Debt to Equity
0.38
Issuance of Debt (TTM)
-$248.17K
Repayment of Debt (TTM)
-$248.17K

Key Statistics

Open
$7.61
Close
$9.75
Volume / Avg.
46.05M / 928.40K
Day Range
$7.54 - $11.75
52 Wk Range
4.56 - 202.50
Market Cap
$5.92M
P/E Ratio
-
Dividend Yield
-
Exchange
NASDAQ
RSI
64
Short Interest
33.36%
Days to Cover
1

About

Sector
Health Care
Industry
Biotechnology
bioAffinity Technologies Inc develops noninvasive diagnostic laboratory tests to detect early-stage lung cancer and other diseases of the lung using flow cytometry and automated analysis informed by machine learning, a form of artificial intelligence...
Show More
Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

FAQ

Q

How do I buy bioAffinity Technologies (BIAF) stock?

A

You can purchase shares of bioAffinity Technologies (NASDAQ:BIAF) through any online brokerage.

View our list of the best stock brokerages

Q

Who are bioAffinity Technologies (BIAF) competitors?

Q

What is the forecast, or price target, for bioAffinity Technologies (BIAF) stock?

A

There is no analysis for bioAffinity Technologies to provide a consensus price target.

Q

What is the current price for bioAffinity Technologies (BIAF)?

A

The stock price for bioAffinity Technologies (NASDAQ: BIAF) is $10 last updated September 2, 2026 at 7:59 PM EDT.

Q

Does bioAffinity Technologies (BIAF) pay a dividend?

A

There are no upcoming dividends for bioAffinity Technologies.

Q

When is bioAffinity Technologies (NASDAQ:BIAF) reporting earnings?

A

bioAffinity Technologies does not have any upcoming earnings scheduled.

Q

Is bioAffinity Technologies (BIAF) going to split?

A

There is no upcoming split for bioAffinity Technologies.

Q

What sector and industry does bioAffinity Technologies (BIAF) operate in?

A

bioAffinity Technologies is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Data & APIs: Benzinga APIs · Stock News API · Analyst Ratings API · Company Logo API

Market data provided by Benzinga APIs

Connect With Us
instagramlinkedinyoutubeblueskymastodon
About Benzinga
Market Resources
Trading Tools & Education
Ring the Bell
© 2026 Benzinga | All Rights Reserved